{"pmid":32395542,"pmcid":"PMC7210180","title":"The challenges in colorectal cancer management during COVID-19 epidemic.","text":["The challenges in colorectal cancer management during COVID-19 epidemic.","It has been over 2 months since the start of the Coronavirus disease 2019 (COVID-19) outbreak. The epidemic stage of COVID-19 has brought great challenges to the diagnosis and management of colorectal cancer (CRC) patients. Symptoms, such as fever and cough caused by cancer, and the therapeutic process (including chemotherapy and surgery) should be differentiated from some COVID-19 related characteristics. Besides, clinical workers should not only consider the therapeutic strategy for cancer, but also emphasize COVID-19's prevention. Moreover, the detailed therapeutic regimens of CRC patients may be different from the usual. Also, treatment principles may various for CRC patients with or without severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, as well as patients with or without an emergency presentation. In this paper, we want to discuss the above-mentioned problems based on previous guidelines, the current working status and our experiences, to provide a reference for medical personnel.","Ann Transl Med","Ren, Xianghai","Chen, Baoxiang","Hong, Yuntian","Liu, Weicheng","Jiang, Qi","Yang, Jingying","Qian, Qun","Jiang, Congqing","32395542"],"abstract":["It has been over 2 months since the start of the Coronavirus disease 2019 (COVID-19) outbreak. The epidemic stage of COVID-19 has brought great challenges to the diagnosis and management of colorectal cancer (CRC) patients. Symptoms, such as fever and cough caused by cancer, and the therapeutic process (including chemotherapy and surgery) should be differentiated from some COVID-19 related characteristics. Besides, clinical workers should not only consider the therapeutic strategy for cancer, but also emphasize COVID-19's prevention. Moreover, the detailed therapeutic regimens of CRC patients may be different from the usual. Also, treatment principles may various for CRC patients with or without severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, as well as patients with or without an emergency presentation. In this paper, we want to discuss the above-mentioned problems based on previous guidelines, the current working status and our experiences, to provide a reference for medical personnel."],"journal":"Ann Transl Med","authors":["Ren, Xianghai","Chen, Baoxiang","Hong, Yuntian","Liu, Weicheng","Jiang, Qi","Yang, Jingying","Qian, Qun","Jiang, Congqing"],"date":"2020-05-13T11:00:00Z","year":2020,"_id":"32395542","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.21037/atm.2020.03.158","keywords":["2019 novel coronavirus disease (covid-19)","severe acute respiratory syndrome corona virus 2 (sars-cov-2)","colorectal cancer (crc)"],"topics":["Diagnosis","Prevention"],"weight":1,"_version_":1666627827797065728,"score":9.490897,"similar":[{"pmid":32100980,"title":"[Chemotherapy strategy for colorectal cancer under the outbreak of novel coronavirus pneumonia].","text":["[Chemotherapy strategy for colorectal cancer under the outbreak of novel coronavirus pneumonia].","The outbreak of novel coronavirus pneumonia (NCP) makes the medical treatment of colorectal cancers difficult. Cancer patients are more susceptible to infection and tumor history is defined as an important factor of poor prognosis, which challenges both doctors and patients. For metastatic colorectal cancer (CRC) patients, maintenance therapy is the optimal choice. The patients with tumor progression or poor biological behaviorshould receive or or continue combination chemotherapy. Adjuvant chemotherapy should reduce the intensity of treatment and shorten the therapy time. Fever patients during chemotherapy need to receive differential diagnosis and screening according to national standards. Patients with stable diseases and good general conditions may delay imaging examination.. Clinicians should make individual clinical decisions based on the specifics of each patient durding epidemic situation.","Zhonghua Wei Chang Wai Ke Za Zhi","Li, Y H","Shen, L","Li, J","32100980"],"abstract":["The outbreak of novel coronavirus pneumonia (NCP) makes the medical treatment of colorectal cancers difficult. Cancer patients are more susceptible to infection and tumor history is defined as an important factor of poor prognosis, which challenges both doctors and patients. For metastatic colorectal cancer (CRC) patients, maintenance therapy is the optimal choice. The patients with tumor progression or poor biological behaviorshould receive or or continue combination chemotherapy. Adjuvant chemotherapy should reduce the intensity of treatment and shorten the therapy time. Fever patients during chemotherapy need to receive differential diagnosis and screening according to national standards. Patients with stable diseases and good general conditions may delay imaging examination.. Clinicians should make individual clinical decisions based on the specifics of each patient durding epidemic situation."],"journal":"Zhonghua Wei Chang Wai Ke Za Zhi","authors":["Li, Y H","Shen, L","Li, J"],"date":"2020-02-27T11:00:00Z","year":2020,"_id":"32100980","source":"PubMed","week":"20209|Feb 24 - Mar 01","doi":"10.3760/cma.j.cn.441530-20200226-00093","keywords":["chemotherapy","colorectal neoplasms","novel coronavirus pneumonia (ncp)"],"topics":["Treatment"],"weight":1,"_version_":1666138492891037696,"score":325.65298},{"pmid":32192297,"title":"[Chemotherapy strategy for colorectal cancer under the outbreak of corona virus disease 2019].","text":["[Chemotherapy strategy for colorectal cancer under the outbreak of corona virus disease 2019].","The outbreak of corona virus disease 2019 (COVID-19) makes the medical treatment of colorectal cancers difficult. Cancer patients are more susceptible to infection and tumor history is defined as an important factor of poor prognosis, which challenges both doctors and patients. For metastatic colorectal cancer (CRC) patients, maintenance therapy is the optimal choice. The patients with tumor progression or poor biological behavior should receive or continue combination chemotherapy. Adjuvant chemotherapy should reduce the intensity of treatment and shorten the therapy time. Fever patients during chemotherapy need to receive differential diagnosis and screening according to national standards. Patients with stable diseases and good general conditions may delay imaging examination. Clinicians should make individual clinical decisions based on the specifics of each patient during epidemic situation.","Zhonghua Wei Chang Wai Ke Za Zhi","Li, Y H","Shen, L","Li, J","32192297"],"abstract":["The outbreak of corona virus disease 2019 (COVID-19) makes the medical treatment of colorectal cancers difficult. Cancer patients are more susceptible to infection and tumor history is defined as an important factor of poor prognosis, which challenges both doctors and patients. For metastatic colorectal cancer (CRC) patients, maintenance therapy is the optimal choice. The patients with tumor progression or poor biological behavior should receive or continue combination chemotherapy. Adjuvant chemotherapy should reduce the intensity of treatment and shorten the therapy time. Fever patients during chemotherapy need to receive differential diagnosis and screening according to national standards. Patients with stable diseases and good general conditions may delay imaging examination. Clinicians should make individual clinical decisions based on the specifics of each patient during epidemic situation."],"journal":"Zhonghua Wei Chang Wai Ke Za Zhi","authors":["Li, Y H","Shen, L","Li, J"],"date":"2020-03-21T11:00:00Z","year":2020,"_id":"32192297","source":"PubMed","week":"202012|Mar 16 - Mar 22","doi":"10.3760/cma.j.cn.441530-20200225-00089","keywords":["chemotherapy","colorectal neoplasms","corona virus disease 2019"],"topics":["Treatment"],"weight":1,"_version_":1666138490064076800,"score":324.99692},{"pmid":32500432,"title":"The impact of COVID-19 pandemic in the colorectal cancer prevention.","text":["The impact of COVID-19 pandemic in the colorectal cancer prevention.","BACKGROUND: The coronavirus disease 2019 (COVID-19) has led to a policy of severe restrictions in almost all countries strongly involved by the pandemic. National Health System is among activities suffering from the COVID-19 and the lockdown. AIM: To evaluate the impact of COVID-19 in colorectal cancer (CRC) prevention. METHODS: We report the change in the hospital organization to meet the growing healthcare needs determined by COVID-19. The limitations of CRC prevention secondary to COVID-19 and their effects on the healthcare are analyzed considering the features of the CRC screening programs in the average-risk population and endoscopic surveillance in patients with inflammatory bowel diseases (IBD). RESULTS: The interruption of CRC prevention may lead to a delayed diagnosis of CRC, possibly in a more advanced stage. The economic burden and the impact on workload for gastroenterologists, surgeons, and oncologists will be greater as long as the CRC prevention remains suspended. To respond to the increased demand for colonoscopy once COVID-19 will be under control, we should optimize the resources. It will be necessary to stratify the CRC risk and reach an order of priority. It should be implemented the number of health workers, equipment, and spaces dedicated to performing colonoscopy for screening purpose and in subjects with alarm symptoms in the shortest time. To this aim, the funds earmarked for healthcare should be increased. CONCLUSION: The economic impact will be dramatic, but COVID-19 is the demonstration that healthcare has to be the primary goal of humans.","Int J Colorectal Dis","Del Vecchio Blanco, Giovanna","Calabrese, Emma","Biancone, Livia","Monteleone, Giovanni","Paoluzi, Omero Alessandro","32500432"],"abstract":["BACKGROUND: The coronavirus disease 2019 (COVID-19) has led to a policy of severe restrictions in almost all countries strongly involved by the pandemic. National Health System is among activities suffering from the COVID-19 and the lockdown. AIM: To evaluate the impact of COVID-19 in colorectal cancer (CRC) prevention. METHODS: We report the change in the hospital organization to meet the growing healthcare needs determined by COVID-19. The limitations of CRC prevention secondary to COVID-19 and their effects on the healthcare are analyzed considering the features of the CRC screening programs in the average-risk population and endoscopic surveillance in patients with inflammatory bowel diseases (IBD). RESULTS: The interruption of CRC prevention may lead to a delayed diagnosis of CRC, possibly in a more advanced stage. The economic burden and the impact on workload for gastroenterologists, surgeons, and oncologists will be greater as long as the CRC prevention remains suspended. To respond to the increased demand for colonoscopy once COVID-19 will be under control, we should optimize the resources. It will be necessary to stratify the CRC risk and reach an order of priority. It should be implemented the number of health workers, equipment, and spaces dedicated to performing colonoscopy for screening purpose and in subjects with alarm symptoms in the shortest time. To this aim, the funds earmarked for healthcare should be increased. CONCLUSION: The economic impact will be dramatic, but COVID-19 is the demonstration that healthcare has to be the primary goal of humans."],"journal":"Int J Colorectal Dis","authors":["Del Vecchio Blanco, Giovanna","Calabrese, Emma","Biancone, Livia","Monteleone, Giovanni","Paoluzi, Omero Alessandro"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32500432","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1007/s00384-020-03635-6","keywords":["covid-19","colonoscopy","colorectal cancer","colorectal cancer screening","fecal occult blood test"],"topics":["Prevention"],"weight":1,"_version_":1668804508778496001,"score":314.26752},{"pmid":32379056,"title":"Modified management mode for colorectal cancer during COVID-19 outbreak - a single-center experience.","text":["Modified management mode for colorectal cancer during COVID-19 outbreak - a single-center experience.","During the epidemic of COVID-19, the management model of colorectal cancer has to be changed at our center due to relatively limited medical resources. Outpatient visits are reduced under well protected after appointment, and rigorous investigation of epidemiological history and clinical symptoms are needed. We prefer a simple and convenient treatment regimen, which may also be postponed appropriately. Minimally invasive CRC surgery combined with a perioperative program of enhanced recovery after surgery should be recommended. We also focus on mental health treatments and healthy lifestyle education. In addition, routine follow-up can be moderately delayed. In total, adequate doctor-patient communication is also recommended throughout the treatment.","Aging (Albany NY)","Zhu, Dexiang","Wu, Qi","Lin, Qi","Wei, Ye","32379056"],"abstract":["During the epidemic of COVID-19, the management model of colorectal cancer has to be changed at our center due to relatively limited medical resources. Outpatient visits are reduced under well protected after appointment, and rigorous investigation of epidemiological history and clinical symptoms are needed. We prefer a simple and convenient treatment regimen, which may also be postponed appropriately. Minimally invasive CRC surgery combined with a perioperative program of enhanced recovery after surgery should be recommended. We also focus on mental health treatments and healthy lifestyle education. In addition, routine follow-up can be moderately delayed. In total, adequate doctor-patient communication is also recommended throughout the treatment."],"journal":"Aging (Albany NY)","authors":["Zhu, Dexiang","Wu, Qi","Lin, Qi","Wei, Ye"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32379056","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.18632/aging.103099","keywords":["covid-19","colorectal cancer","management model"],"topics":["Prevention"],"weight":1,"_version_":1666262687590383616,"score":291.64108},{"pmid":32420073,"pmcid":"PMC7225133","title":"Challenges and countermeasures of thoracic oncology in the epidemic of COVID-19.","text":["Challenges and countermeasures of thoracic oncology in the epidemic of COVID-19.","Since December, 2019, a 2019 novel coronavirus disease (COVID-19) infected by the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) emerged in Wuhan, Hubei province, and the epidemic situation has continued to spread globally. The epidemic spread of COVID-19 has brought great challenges to the clinical practice of thoracic oncology. Outpatient clinics need to strengthen the differential diagnosis of initial symptoms, pulmonary ground-glass opacity (GGO), consolidation, interstitial and/or interlobular septal thickening, and crazy paving appearance. In the routine of oncology, the differential diagnosis of adverse events from COVID-19 is also significant, including radiation pneumonitis, checkpoint inhibitor pneumonitis (CIP), neutropenic fever, and so on. During the epidemic, indications of transbronchial biopsy (TBB) and CT-guided percutaneous thoracic biopsy are strictly controlled. For patients who are planning to undergo biopsy operation, screening to exclude the possibility of COVID-19 should be carried out. For confirmed or suspected patients, three-level protection should be performed during the operation. Disinfection and isolation measures should be strictly carried out during the operation. At last, more attention to the protection of cancer patients and give priority to the treatment of infected cancer patients.","Transl Lung Cancer Res","Guo, Haoyue","Chen, Xiaoxia","Su, Chunxia","Liu, Yu","Wang, Hao","Sun, Chenglong","Chen, Peixin","Jiang, Minlin","Xu, Yi","Wu, Shengyu","Jia, Keyi","Zhao, Sha","Li, Wei","Chen, Bin","Wang, Lei","Yu, Jia","Xiong, Anwen","Gao, Guanghui","Wu, Fengying","Li, Jiayu","Ye, Lingyun","Bo, Bing","Chen, Shen","Ren, Shengxiang","He, Yayi","Zhou, Caicun","32420073"],"abstract":["Since December, 2019, a 2019 novel coronavirus disease (COVID-19) infected by the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) emerged in Wuhan, Hubei province, and the epidemic situation has continued to spread globally. The epidemic spread of COVID-19 has brought great challenges to the clinical practice of thoracic oncology. Outpatient clinics need to strengthen the differential diagnosis of initial symptoms, pulmonary ground-glass opacity (GGO), consolidation, interstitial and/or interlobular septal thickening, and crazy paving appearance. In the routine of oncology, the differential diagnosis of adverse events from COVID-19 is also significant, including radiation pneumonitis, checkpoint inhibitor pneumonitis (CIP), neutropenic fever, and so on. During the epidemic, indications of transbronchial biopsy (TBB) and CT-guided percutaneous thoracic biopsy are strictly controlled. For patients who are planning to undergo biopsy operation, screening to exclude the possibility of COVID-19 should be carried out. For confirmed or suspected patients, three-level protection should be performed during the operation. Disinfection and isolation measures should be strictly carried out during the operation. At last, more attention to the protection of cancer patients and give priority to the treatment of infected cancer patients."],"journal":"Transl Lung Cancer Res","authors":["Guo, Haoyue","Chen, Xiaoxia","Su, Chunxia","Liu, Yu","Wang, Hao","Sun, Chenglong","Chen, Peixin","Jiang, Minlin","Xu, Yi","Wu, Shengyu","Jia, Keyi","Zhao, Sha","Li, Wei","Chen, Bin","Wang, Lei","Yu, Jia","Xiong, Anwen","Gao, Guanghui","Wu, Fengying","Li, Jiayu","Ye, Lingyun","Bo, Bing","Chen, Shen","Ren, Shengxiang","He, Yayi","Zhou, Caicun"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32420073","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.21037/tlcr.2020.02.10","keywords":["2019 novel coronavirus disease (covid-19)","severe acute respiratory syndrome corona virus 2 (sars-cov-2)","thoracic oncology"],"locations":["Wuhan","Hubei","thoracic","thoracic","thoracic"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1667254896752066560,"score":272.5354}]}